A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
Principal Investigator
John SwistonOverview
Study Start/End
Dec 7, 2016 to Dec 31, 2018Locations
Diamond Health Care Centre, Vancouver General Hospital
Name/Title
Mami Okada, Research CoordinatorPhone
604-875-4111 ext.69831Email Address
mami.okada@vch.caPurpose of Study
This study assesses the safety and efficacy of bardoxolone methyl relative to placebo in patients with connective tissue disease-associated pulmonary arterial hypertension to determine the recommended dose range and evaluate the change from baseline in 6-minute walk distance (6MWD) following 24 weeks of study participation.
Eligibility
Visit ClinicalTrials.gov for more information.
Disclaimer
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.